These proto-oncogenes were found to be over expressed in 80% of cancers such as breast cancer, cervical cancer, lung cancer, etc. The promoter region of c-myc gene is composed of seven nuclease-hypersensitive elements (NHEs), of which, NHE III1 controls 80–90% transcription of c-myc gene. This evidence concerns the gene MYC and lung carcinoma.